Earnings Call for Q2FY21 Aarti Drugs
Conference Call with Aarti Drugs Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.26-10-2020
26-10-2020
AARTI DRUGS LTD. - 524348 - Fixes Record Date for Interim Dividend
Aarti Drugs Ltd has informed BSE that the Company has fixed November 04, 2020 as the Record Date for the purpose of Payment of Interim Dividend.24-10-2020
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Monday, October 26, 2020 at 3:00 PM IST to discuss the Company's Q2 FY21 Results. Please find attached herewith invitation for the same.23-10-2020
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Monday, October 26, 2020 at 3:00 PM IST to discuss the Company's Q2 FY21 Results. Please find attached herewith invitation for the same.23-10-2020
Aarti Drugs Ltd - 524348 - Outcome Of The Board Meeting - Fund Raising
Outcome of the Board Meeting - Fund Raising23-10-2020
Aarti Drugs Ltd - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2020
We wish to inform you that Board of Directors at its Meeting held on Friday, October 23, 2020, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2020.23-10-2020
Aarti Drugs Ltd - 524348 - Corporate Action-Board approves Dividend
We wish to inform you that Board of Directors of the Company at its Meeting held on Friday, October 23, 2020, has declared the Interim Dividend @ Rs. 2.5/- (25%) per Equity share for the financial year 2020-21. Please note that as per Regulation 42(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Wednesday, November 04, 2020 has been fixed as 'Record Date' for the purpose of payment of Interim Dividend.23-10-2020
Aarti Drugs Ltd - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2020
We wish to inform you that Board of Directors at its Meeting held on Friday, October 23, 2020, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 202023-10-2020
AARTI DRUGS LTD. - 524348 - Board to cosider Interim Dividend
With reference to the earlier announcement dated October 17, 2020, Aarti Drugs Ltd has now informed BSE that the Board of Directors propose to consider following items in its meeting scheduled to be held on October 23, 2020.1. To consider and declare Interim dividend for the FY 2020-21, if any.2. To consider the fund raising, subject to such approvals as may be required including the approval of the members at a general meeting or through postal ballot and further subject to such other statutory / regulatory approvals, as applicable.In pursuance to the intimation dated September 29, 2020, the trading window of the Company shall remain closed until October 25, 2020 for the aforesaid purpose.20-10-2020